Profen and Allergic sinusitis - a phase IV clinical study of FDA data

Summary:

Allergic sinusitis is reported as a side effect among people who take Profen (ibuprofen), especially for people who are female, 50-59 old, have been taking the drug for 1 - 6 months also take Celebrex, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Allergic sinusitis when taking Profen. It is created by eHealthMe based on reports of 239,319 people who have side effects when taking Profen from the FDA, and is updated regularly.

What is Profen?

Profen has active ingredients of ibuprofen. It is often used in pain. eHealthMe is studying from 245,311 Profen users. Check the latest studies of Profen.

What is Allergic sinusitis?

Allergic sinusitis is found to be associated with 218 drugs and 240 conditions by eHealthMe. Check the latest studies of Allergic sinusitis.

On Jul, 06, 2026

239,319 people reported to have side effects when taking Profen.
Among them, 47 people (0.02%) have Allergic sinusitis.

Among these 47 people:

How long have people been on Profen when they have Allergic sinusitis? *

What is the gender of people who have Allergic sinusitis when taking Profen? *

female: 89.36 %
male: 10.64 %

What is the age of people who have Allergic sinusitis when taking Profen? *

What are other drugs people take besides Profen? *

What are other side effects people have besides Allergic sinusitis? *

Fever: 27 people, 57.45%
Joint Pain: 24 people, 51.06%
Pain In Extremity: 23 people, 48.94%
Tendonitis (a condition that causes pain and swelling of tendons): 22 people, 46.81%
Rashes (redness): 22 people, 46.81%
Drug Ineffective: 20 people, 42.55%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 20 people, 42.55%
Alanine Aminotransferase Increased: 19 people, 40.43%
Hepatic Enzyme Increased: 19 people, 40.43%
Antinuclear Antibody Positive: 19 people, 40.43%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 22 people, 46.81%
Blood Uric Acid Increased: 19 people, 40.43%
Arrhythmias (irregular heartbeat): 19 people, 40.43%
Immunodeficiency Common Variable: 7 people, 14.89%
Dermatomyositis (inflammation of the skin and underlying muscle tissue, typically occurring as an autoimmune condition or associated with internal cancer): 3 people, 6.38%
Myopathy (a muscular disease in which the muscle fibres do not function): 3 people, 6.38%
Sinus Disorder (disease of sinus): 2 people, 4.26%
Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 2 people, 4.26%
Cough: 2 people, 4.26%
Cardiac Disorder: 1 person, 2.13%

* Approximation only. Some reports may have incomplete information.

Do you take Profen and have Allergic sinusitis?

- Check whether Allergic sinusitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Profen:

Profen (245,311 reports)

Browse all side effects of Profen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Allergic sinusitis:

Allergic sinusitis (218 drugs)

Browse all the conditions that are associated with Allergic sinusitis:

Allergic sinusitis (240 conditions)

Related publications that referenced our studies

Moslim MA, Sodeman TC, Nawras AT, "A Case of Suggested Ibuprofen-Induced Acute Pancreatitis", American journal of therapeutics, 2016 Nov .
Moslim MA, Sodeman TC, Nawras AT, "A Case of Suggested Ibuprofen-Induced Acute Pancreatitis", American journal of therapeutics, 2016 Nov .

How the study uses the data?

The study uses data from the FDA. It is based on ibuprofen (the active ingredients of Profen) and Profen (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.